Document is current
Any future updates will be listed below
-
Authors
Kim, Daniel Seung https://orcid.org/0000-0003-2971-1909
Eltahir, Ahmed
Mantena, Sriya
Doijad, Ritu
Matabang, Christian
Rodriguez, Fatima
-
Funding
Funding for this research was provided by:
American Diabetes Association (7-25-INI-11)
American Heart Association (25CDA1436622)
National Institutes of Health (1L30HL170306, 9L30DK144879)
Robert A. Winn Excellence in Clinical Trials
- License Information
-
More Information
Article History
Received: 8 July 2025
Accepted: 28 October 2025
First Online: 2 December 2025
Competing interests
: D.S.K. reports grant support from Amgen and the Bristol Myers Squibb Foundation (via the Robert A. Winn Excellence in Clinical Trials Career Development Award), outside the submitted work. F.R. reports equity from Carta Healthcare and HealthPals, and consulting fees from HealthPals, Novartis, Novo Nordisk, Esperion Therapeutics, Movano Health, Kento Health, Inclusive Health, Edwards, Arrowhead Pharmaceuticals, HeartFlow, and iRhythm outside the submitted work. The remainder of the authors declare no competing interests.
